» Articles » PMID: 29387863

MiR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha

Overview
Journal Mol Med
Publisher Biomed Central
Date 2018 Feb 2
PMID 29387863
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The kidney is vulnerable to hypoxia-induced injury. One of the mechanisms underlying this phenomenon is cell apoptosis triggered by hypoxia-inducible factor-1-alpha (HIF-1α) activation. MicroRNA-210 (miR-210) is known to be induced by HIF-1α and can regulate various pathological processes, but its role in hypoxic kidney injury remains unclear. Here, in both kinds of rat systemic hypoxia and local kidney hypoxia models, we found miR-210 levels were upregulated significantly in injured kidney, especially in renal tubular cells. A similar increase was observed in hypoxia-treated human renal tubular HK-2 cells. We also verified that miR-210 can directly suppress HIF-1α expression by targeting the 3' untranslated region (UTR) of HIF-1α mRNA in HK-2 cells in severe hypoxia. Accordingly, miR-210 overexpression caused significant inhibition of the HIF-1α pathway and attenuated apoptosis caused by hypoxia, while miR-210 knockdown exerted the opposite effect. Taken together, our findings verify that miR-210 is involved in the molecular response in hypoxic kidney lesions and attenuates hypoxia-induced renal tubular cell apoptosis by targeting HIF-1α directly and suppressing HIF-1α pathway activation .

Citing Articles

Hypoxia-preconditioned WJ-MSC spheroid-derived exosomes delivering miR-210 for renal cell restoration in hypoxia-reoxygenation injury.

Toghiani R, Azimian Zavareh V, Najafi H, Mirian M, Azarpira N, Abolmaali S Stem Cell Res Ther. 2024; 15(1):240.

PMID: 39080774 PMC: 11289969. DOI: 10.1186/s13287-024-03845-7.


Biomarkers in renal cell carcinoma and their targeted therapies: a review.

Gupta S, Kanwar S Explor Target Antitumor Ther. 2023; 4(5):941-961.

PMID: 37970211 PMC: 10645469. DOI: 10.37349/etat.2023.00175.


Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming.

Rahbar Saadat Y, Hosseiniyan Khatibi S, Sani A, Zununi Vahed S, Ardalan M Inflammopharmacology. 2023; 31(4):1657-1669.

PMID: 37131045 DOI: 10.1007/s10787-023-01232-x.


Elevation of Circulating miR-210 Participates in the Occurrence and Development of Type 2 Diabetes Mellitus and Its Complications.

Chen X, Tian F, Sun Z, Zeng G, Tang P J Diabetes Res. 2022; 2022:9611509.

PMID: 36465705 PMC: 9711992. DOI: 10.1155/2022/9611509.


Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner.

Wei J, Hu M, Chen X, Lei F, Wei J, Chen J Ren Fail. 2022; 44(1):2056-2065.

PMID: 36420656 PMC: 9704099. DOI: 10.1080/0886022X.2022.2148539.


References
1.
Horkan C, Purtle S, Mendu M, Moromizato T, Gibbons F, Christopher K . The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*. Crit Care Med. 2014; 43(2):354-64. DOI: 10.1097/CCM.0000000000000706. View

2.
Wang E, Gang H, Aviv Y, Dhingra R, Margulets V, Kirshenbaum L . p53 mediates autophagy and cell death by a mechanism contingent on Bnip3. Hypertension. 2013; 62(1):70-7. DOI: 10.1161/HYPERTENSIONAHA.113.01028. View

3.
Wang F, Xiong L, Huang X, Zhao T, Wu L, Liu Z . miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res. 2013; 11(1):657-67. DOI: 10.1016/j.scr.2013.04.005. View

4.
Legrand M, Mik E, Johannes T, Payen D, Ince C . Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med. 2008; 14(7-8):502-16. PMC: 2386087. DOI: 10.2119/2008-00006.Legrand. View

5.
Thadhani R, Pascual M, Bonventre J . Acute renal failure. N Engl J Med. 1996; 334(22):1448-60. DOI: 10.1056/NEJM199605303342207. View